Author Archives: Cindy Affandi

BIOTECH

STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment

STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines...

Read more

DIGITAL CLINICAL SOLUTION

RegASK announces US$10m Series A Funding Round led by Monograph Capital to accelerate its growth

SINGAPORE, Dec. 15, 2022 /PRNewswire/ — RegASK, a global RegTech SaaS company, today announced it has raised a $10m Series A...

Read more

BIOTECH

AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V

The transaction reflects a pre-money equity value of $400 million for AUM Biosciences Transaction is...

Read more

BIOTECH

Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01

Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders...

Read more

DIGITAL CLINICAL SOLUTION

ObvioHealth Introduces ObvioGo™, a Next-Generation DCT Platform and Mobile Application Delivering Stronger Evidence

NEW YORK – September 14, 2022 –  ObvioHealth, a pioneering virtual research organization (VRO), announces...

Read more